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Background: Peer-reviewed studies suggest that a hostile gestational environment is
associated with delayed neurological development in infants. Autism spectrum disorder
(ASD) is estimated to affect 1 in 59 children in the United States; however, few studies have
specifically investigated risk factors for autism in Hispanic children. Purpose: The
University of Texas RGV Hispanic Autism Research Center (HARC) studied Hispanic
children with ASD and their biological mothers to identify potential environmental exposures
and prenatal risk factors that could impact the risk for ASD through preliminary research in
the Rio Grande Valley. Methods: This pilot study recruited 25 Hispanic mothers and their
biological children with autism and 25 Hispanic control mothers and children. Participants
completed a twelve-section survey that included specific prenatal risk factors, such as
illnesses and medications taken during pregnancy. The goal was to evaluate if specific
maternal prenatal risk factors are associated with a higher prevalence of ASD among
Hispanic children living on the US-Mexico border. Results: Descriptive analysis showed a
higher proportion of vaginal bleeding and urinary tract infections (UTIs) during gestation in
v

mothers of children with autism than control mothers. We also found evidence of an
association between ASD in children and mothers who experience vaginal bleeding, UTIs,
and allergies. No significant inferences can be drawn of maternal medicines taken during
gestation and ASD in the child. Conclusion: This pilot study adds to the body of research
suggesting maternal inflammation contributes towards increasing autism risk. The results are
consistent with peer-reviewed studies that included a varied racial/ethnic study population,
suggesting no difference in risk factors between Hispanic women and women of other races.
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BACKGROUND

Literature Review
Autism
Autism spectrum disorder (ASD) is a neurodevelopmental disability that can cause
significant social, communication, and behavioral challenges (CDC, 2018). Symptoms are
typically detected during childhood and sustain throughout life. The condition was initially
called “autism”, but identification of the disorder was put on a spectrum in the early 1990s
when it became apparent that autism could not be defined by a specific set of symptoms or
severity (CDC, 2018). Symptoms range from communicational and social deficits and
repetitive behaviors, such as a child not responding when their name is called, avoiding eye
contact, or trouble adapting to routine changes (CDC, 2018). The prevalence of ASD is
currently estimated at 1 in 59 United States children, affecting approximately 4 times as
many males as females (Baio, Wiggins, & Christensen, 2018). The causes of ASD are still
unknown, but it is hypothesized to have moderate genetic heritability in combination with
environmental factors (Hallmayer, et al., 2011).
Autism among Hispanic people
White non-Hispanic children have ASD prevalence rates 1.2x higher than Hispanic
children Invalid source specified.. While genetics and environmental exposures have not
been excluded as possible causes for the disparity, the most likely cause is underdiagnosis of
ASD in Hispanic children (Palmer, Walker, Mandell, Bayles, & Miller, 2010). Hispanic
families are more likely to be of lower socioeconomic status and lack health insurance or
1

financial resources to seek medical attention (Palmer, Walker, Mandell, Bayles, & Miller,
2010). Outside of economic determinants however, gaps in education and cultural differences
may additionally contribute to the underdiagnosis of autism spectrum disorder in Hispanic
children (Zuckerman, et al., 2017) (Ijalba, 2016).
In one study, Latinos with limited English proficiency disproportionately experienced
barriers to seeking ASD diagnosis and treatment compared to Non-Latino Whites and
Latinos with English proficiency (Zuckerman, et al., 2017). While all study groups reported
the barrier “stress of the diagnostic process” most frequently, “parent knowledge about ASD”
was the most common barrier in Latino families regardless of English proficiency. “Parent
trust in providers” was a statistically significant more common barrier among Latinos with
limited English proficiency than in Non-Latino Whites (Zuckerman, et al., 2017). This study
demonstrates that English proficiency is a crucial indicator of overcoming barriers to seeking
ASD diagnosis and treatment.
Several studies have found a lower level of trust in health institutions by racial/ethnic
minority groups, specifically African Americans and Hispanic Americans, compared to NonHispanic Whites (Schwei, Kadunc, Nguyen, & Jacobs, 2014). Hispanics are three times as
likely as non-Hispanic whites to lack a regular health care provider and 83% of Hispanic
participants reported obtaining health information from media, with television being the
dominant source (Pew Research Center, 2008). Some reasons for health institution distrust by
Hispanics include a distrust in Western medicine, lack of cultural competency by medical
providers, and fear of judgement by medical providers towards Hispanic culture and lifestyle
(Julliard, et al., 2008). Zuckerman et al. stated, “families with higher maternal education and
2

ASD knowledge have better access to ASD care regardless of ethnicity”. However, many
Hispanic families originate from other countries with little awareness of ASD or few
resources devoted to children with disabilities (Ijalba, 2016). A study found that all fourteen
Hispanic mothers of children with ASD believed their child’s condition was temporary
(Ijalba, 2016). Therefore, a history of little ASD education combined with general distrust in
Western providers contribute as barriers to seeking ASD diagnosis and treatment (Ijalba,
2016) (Zuckerman, et al., 2017) (Julliard, et al., 2008).
Additionally, cultural beliefs in the Hispanic community are believed to play an
important role in the underdiagnoses of ASD in children, as evidenced in the Ijalba study that
interviewed fourteen Hispanic mothers of children with ASD (Ijalba, 2016). The Hispanic
community has a very strong relationship with the Catholic faith, and for this reason many
mothers in the study relied on their faith or divine intervention to cure their child rather than
seeking medical attention (Ijalba, 2016). Other Hispanic beliefs, such as susto and familismo,
played roles in a mother not seeking treatment for her child. Susto is the Mexican belief that
an acute traumatic or fearful event can cause illness (Ijalba, 2016). While a susto event can
be obvious and physical, other events may be apparent only to the child. In the Ijalba study,
four out of fourteen mothers reported believing an event of susto caused their child’s ASD,
with the results being immediate. One mother describes that her 18-month-old was
developing normally until one day, “Suddenly, he turned to the window and saw something,
he covered his eyes and cried and would not stop” (Ijalba, 2016). Upon waking up the next
day, the child did not speak anymore and would eventually be diagnosed with ASD (Ijalba,
2016). Familismo is a defined as “the strong sense of interdependency and shared decision
3

making in many Hispanic families” and is an important cultural norm in many Hispanic
communities (Ijalba, 2016). Mothers of children with ASD sought the advice of family
members, such as grandmothers, who would assure that the child comes from a family
history of delayed speech or insist that the mother wait longer before seeking professional
attention. In the study, seven of the fourteen interviewed mothers were advised that “children
can be late with language” or “father was a late talker” by family members (Ijalba, 2016).
Language barriers, lack of ASD education, and cultural beliefs all play a role in
preventing Hispanic mothers from seeking medical attention for their child with ASD (Ijalba,
2016) (Zuckerman, et al., 2017). We will now delve into a hypothesis concerning the
biological pathway maternal inflammation may play a role in ASD development in the child.
Maternal Inflammation
Maternal infection during gestation is a known risk factor for autism and has also
been linked as a risk factor to other neurological disorders such as schizophrenia and cerebral
palsy (Patterson, Immune involvement in schizophrenia and autism: Etiology, pathology and
animal models, 2008). A proposed mechanism is that a maternal immune response to
infection causes an elevation of pro-inflammatory cytokines, which activate a fetal
inflammatory response that may interrupt proper neurodevelopment (Burd, Balakrishnan, &
Kannan, 2012). Because the fetal immune system is underdeveloped and vulnerable to
infection, the fetus begins gestation with an increased concentration of inflammatory proteins
for protection that decrease with gestational age (Burd, Balakrishnan, & Kannan, 2012). Any
imbalance of these inflammatory proteins could play a role in injuring a developing brain
(Burd, Balakrishnan, & Kannan, 2012).
4

Scientists have identified key indicators of immune dysregulation in the brains of
children with autism, including upregulation of cytokines and activated microglia and
astrocytes. These indicators are found in the brains of children, suggesting an early initiation,
as well as adult brains, which suggests a permanent state (Burd, Balakrishnan, & Kannan,
2012). Cytokines possibly act on the fetus through three different pathways: transplacental
passage of maternal cytokines, placental production and secretion of cytokines, or fetal
production of cytokines (Burd, Balakrishnan, & Kannan, 2012). Animal experiments have
been able to demonstrate the effects of a “maternal inflammation risk factor” with cytokine
releasing treatments that activate an immune response in mice, even in the absence of a
pathogen (Patterson, 2011). Offspring of activated mice exhibited behavioral abnormalities
consistent with ASD, including deficits in communication social interaction and elevated
anxiety (Patterson, 2011).
The specific cytokine responsible is still in question. Increased levels of the cytokine
IFN-γ were noted in the midgestational serum of mothers of children with ASD, with a 50%
increased risk per one-unit increase (on the natural log scale) for development of ASD
relative to typically developing controls. IFN-γ is involved in defense against intracellular
pathogens, auto-immunity, and allergy (Goines, et al., 2011). This is consistent with studies
that associate higher incidence of allergies and autoimmune diseases in mothers of children
with ASD than mothers of typically developing children (Croen, Grether, & Yoshida, 2005).
Peripheral IFN-γ levels are typically low in healthy pregnancies, and elevated levels have
been associated with complications such as preeclampsia (Goines, et al., 2011). Additionally,
a maternal immune response could activate the signaling pathway for IL-6, which is one of
5

few cytokines that may cross the placenta and strongly affect fetal development (Patterson,
Immune involvement in schizophrenia and autism: Etiology, pathology and animal models,
2008). Injection of IL-6 alone into mice is enough to generate abnormal behaviors and
changes in brain expression in offspring (Patterson, 2011). Conversely, development of these
behaviors is prevented when IL-6 is blocked during maternal immune activation, suggesting
direct correlation between IL-6 expression and behaviors similar to ASD (Patterson, 2011).
Regardless of which cytokine is directly responsible for ASD in offspring, there are
several proposed pathways of action causing injury to neural cells (Burd, Balakrishnan, &
Kannan, 2012). Probable mechanisms by pro-inflammatory cytokines may include direct
injury to oligodendrocytes and neurons, secondary injury through activation of microglial
cells, or a combination of both direct and secondary injury (Burd, Balakrishnan, & Kannan,
2012). Burd et al. created a diagram demonstrating possible mechanisms of fetal brain injury
in response to maternal inflammation (Figure 1).
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Figure 1: Possible mechanisms for fetal brain injury by maternal inflammation (Burd,
Balakrishnan, & Kannan, 2012)

Public Health Significance
Autism spectrum disorder is currently considered one of the most common child
morbidities (Wang, Geng, Liu, & Zhang, 2017). The public costs of supporting individuals
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with ASD are a multi-billion-dollar endeavor (Buescher, Cidav, & Knapp, 2014). The cost of
supporting a child with ASD during his or her lifespan in the United States is $2.4 million if
the child has an intellectual disability and $1.4 million if the child is without intellectual
disability (Buescher, Cidav, & Knapp, 2014). The largest cost components for children were
special education services and parental productivity loss (Buescher, Cidav, & Knapp, 2014).
Assuming 40% prevalence of intellectual disability in children with ASD, the aggregate
national cost in the United States is $61 billion per year (Buescher, Cidav, & Knapp, 2014).
When calculating for adulthood, the highest cost components were supporting living
accommodations and individual productivity loss. Assuming 40% prevalence of intellectual
disability in adults with ASD, the aggregate national cost is $175 billion per year in the
United States (Buescher, Cidav, & Knapp, 2014). Medical bills to care for adults with ASD
were higher than for children with ASD (Buescher, Cidav, & Knapp, 2014).
The causes and consequences of ASD in Hispanic populations in the United States is
incompletely understood. However, the previously discussed literature about the potential
impacts of commonly held cultural beliefs in many Hispanic communities on knowledge
about ASD and distrust of medical professionals warrants further study (Ijalba, 2016)
(Schwei, Kadunc, Nguyen, & Jacobs, 2014). More specifically, the border communities that
reside on the Texas/Mexico border suffer from lack of access to quality healthcare. The PCP
to patient ratios in Hidalgo County and Cameron County of the Rio Grande Valley are
2,230:1 and 2,200:1, respectively, while the state average is 1,670:1. Both counties have
uninsured rates of 30% (Torres, 2018). Additionally, Hispanic mothers often turn to family
or cultural beliefs before seeking professional medical attention when their child exhibits
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behaviors that are consistent with early signs of ASD (Ijalba, 2016). The investigation of
prenatal risk factors for ASD among Hispanic mothers are needed to understand the public
health burden of ASD in border communities – including potentially unique risk factors.
Research Objectives
In 2008, the autism prevalence rate was 1 in 88 children. In 2010 and 2012, the rates
increased to 1 in 68 and 1 in 69 children, respectively. The most recent 2014 data suggests an
autism prevalence of 1 in 59 children (CDC, 2019). Research towards identification of ASD
has improved the accuracy of diagnosis; however, further research of prevention and
identification of risk factors in pregnant Hispanic women is lacking. The overall goal of this
research is to identify prenatal risk that could impact the risk of ASD in Hispanic children on
the Texas/Mexico border of children between the ages of 2-21 years old at time of the study.
Specifically, we aimed to:
1. Identify prenatal risk factors of ASD by comparing Hispanic women who
gave birth to children with ASD and Hispanic women who gave birth to
typically developing children
2. Compare the prevalence of prenatal risk factors of maternal illnesses and
maternal medications taken during gestation among Hispanic women living
on the border to the general population
3. Investigate effects of maternal inflammation on risk of giving birth to a child
with ASD

9

METHODS
Study Design
We completed a secondary analysis of data previously collected from a case control
study of 25 cases and 25 controls. Ideally, we would have gathered data from a greater
number of participants; however, funding limitations necessitated capping the recruitment of
this initial pilot study.
Study Setting
The Rio Grande Valley of southern Texas is 90% Hispanic and borders Mexico,
making it an ideal location to conduct this preliminary study (U.S. Census, 2017). The
Hispanic Autism Research Center (HARC) sought to identify environmental exposure and
prenatal risk factors in Hispanic children or their biological mothers that could cause ASD in
the children (Palmer, 2014). The HARC pilot study was conducted by The University of
Texas Rio Grande Valley (UTRGV).
Study Subjects
Eligibility Criteria
Inclusion criteria for all child participants included: (a) a child between the ages of 221 years old; (b) living with at least one biological parent; (c) has a parent who speaks
English or Spanish; (d) residing in the study catchment areas of Harlingen and Brownsville,
Texas, covering Hidalgo and Cameron counties, or no more than a 2-hour drive from these
assessment sites (e) of Mexican American ethnicity (Palmer, 2014). Mexican American
ethnicity was determined by the San Antonio Heart Study (SAHS) algorithm, a nine-item
indicator which uses parental surnames, birthplace of both parents, self-declared ethnic
10

identity, and ethnic background of grandparents (Palmer, 2014). Inclusion for parent
participants included: (a) biological parent to a child between the ages of 2-21 years old; (b)
living with the participant child; (c) parent who speaks English or Spanish; (d) residing in the
study catchment areas of Harlingen and Brownsville, Texas, covering Hidalgo and Cameron
counties, or no more than a 2-hour drive from these assessment sites (e) of Mexican
American ethnicity (Palmer, 2014).
Children in the case group were children with a clinical diagnosis of Autism
Spectrum Disorder, including Autism, Asperger’s, and Pervasive Developmental Disorder
Not Otherwise Specified (PDD-NOS) (Palmer, 2014). Adults in the case group were the
biological parents of participating children in the case group. Children in the control group
were typically developing children sampled from the general population. Adults in the
control group were the biological parents of participating children in the control group.
Exclusion criteria for cases were children or parents of children diagnosed with other
neurological disabilities or are non-Mexican American. Exclusion criteria for controls were
children or parents of children who do not have a clinical diagnosis of ASD or are nonMexican American (Palmer, 2014). Due to budgetary restraints, we were unable to match
controls based on age and gender to cases. For the purposes of this pilot study, 25 cases and
25 controls were recruited.
Recruitment
Multiple organizations participated in the recruitment, including an organization of
community healthcare workers called Promotoras de Salud and The Easter Seals of the
Lower Rio Grande Valley (Palmer, 2014). The connections Promotoras de Salud had with
11

school districts, faith-based entities, and other community-based organizations were useful
tools in recruitment for this study because the promotoras had established a high level of
trust and reached out to families personally through home visits and phone calls. Recruitment
also relied heavily on the McAllen and Harlingen centers of The Easter Seals of the Rio
Grande Valley, referrals, and advertisement (Palmer, 2014). The potential subject’s parent(s)
responded to advertisements or referrals from local healthcare providers (community
partners), including Promotoras de Salud and Easter Seals. Research staff then coordinated
recruitment (Palmer, 2014).
The research personnel conducted the screening process over the phone and/or in
person in a private setting (Palmer, 2014). Study coordinators used a standardized script to
determine eligibility, and research personnel verified that each participant met the eligibility
criteria (Palmer, 2014). If the participant met initial eligibility criteria, the participant was
scheduled complete the questionnaire (Palmer, 2014).
Consent Process
After the initial phone screen and if the family agrees to further participation, a
research visit was scheduled at the Clinical Research Unit (CRU) (Palmer, 2014). A
description of the study was provided verbally and in written form (Palmer, 2014). Any
questions the participants had were answered at the time. Research coordinator or study staff
guided the family through the protocol (Palmer, 2014).
All participants signed a form authorizing research to use Protected Health
Information (PHI)/Private identifiable information (Palmer, 2014). PHI was collected during
screening for eligibility. All participants signed a consent form and a HIPPA Waiver after
12

reading detailed risks, benefits, alternatives, and compensation from the research (Palmer,
2014). Study staff obtained written informed consent at the first research meeting before
surveys were administered.
Adequate timing was given to parent(s) to consult with family members to obtain
consent (Palmer, 2014). Research team members asked the parent(s) to repeat back what it is
they were consenting to and the research team determined if they were able to understand the
project well enough to consent (Palmer, 2014). After explaining the goals of the study
protocol in-person to parent(s), those who could not explain in their own words the purpose
of the study were deemed unable to provide consent, and their child was not enrolled
(Palmer, 2014). The same process took place for Spanish speaking individuals to ensure
comprehension among both languages.
Participants were compensated with $150 upon completion of the study in addition to
a $50 travel allowance (Palmer, 2014). The study was at no cost to the participant.
Data Handling and Record Keeping
All surveys are stored in a locked repository at The University of Texas Rio Grande
Valley (UTRGV) Harlingen Clinical Education Building, 2102 Treasure Hills Boulevard,
Harlingen, TX 78550 (Palmer, 2014). The Principal Investigator (Beatriz Tapia, MD, MPH,
EdD) is responsible for the repository (Palmer, 2014). Other researchers requesting
information from the repository must have the approval of the PI (Palmer, 2014). Data
remains on paper surveys in the repository until coded into Microsoft Excel. All electronic
documents containing survey data are saved on a password-protected flash drive.
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Each survey was labeled with respondent’s unique study ID. The code linking ID
numbers to other personal identifying information is kept in a locked file cabinet, and in
electronic files that do not contain any other information and do not exist on computers
containing any other information about the participants.
Data Collection and Abstraction
The thirteen-part survey was created to evaluate environmental causes and prenatal
risk factors and administered in-person to participating mothers (Figure 2). Participants
scheduled a time to take the survey with a member of the research team present (Palmer,
2014). Surveys were administered in-person by a member of the research team between July
2011 and August 2014. The questionnaire took approximately 2-3 hours per participant and
administration was conducted in private room at the Clinical Research Unit (CRU). All
survey answers were written by the mothers onto the survey, and research personnel were
available for clarification of questions. Data was recorded on paper and transferred to
Microsoft Excel for coding and analysis.
Abstraction of recorded survey answers from paper to Microsoft Excel included
coding for multiple choice and free response answers. Coding keys for data abstraction are
described in an accompanying codebook. The standard coding for close ended answers are:
1
0
996
997
998
999

yes
no
refuse to answer
don't know
cannot code or missing
not applicable

14

Open ended answers were transferred directly into Excel as they were written into the
survey.
Data Analysis
Part 7 of the survey pertains to questions concerning “Maternal Illness, Medications,
and Procedures during Pregnancy”. Data from Part 7 was used to test prenatal risk factors.
Specifically, we investigated the association between maternal illnesses and medications
during pregnancy and ASD. We assessed differences in prevalence of prenatal risk factors
were between case mothers and control mothers. Because of the small sample size, all
statistical tests were non-parametric. All analysis was conducted using STATA 15.
Human Subjects, Animal Subjects, or Safety Considerations
This study is a secondary analysis of data that has already been collected. This study
involves human subjects and is therefore subject to the Committee for Protection of Human
Subjects. Participants have the right to refuse to participate in any aspect of the study or to
withdraw from the study at any time. All survey data was deidentified, so the risk to humans
physically/mentally is minimal. This study has been approved by the IRB.
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Figure 2: Index of survey provided to participant mothers concerning environmental and
prenatal risk factors for ASD in the child
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RESULTS
Characteristics of Study Cohort
Demographics of known risk factors include maternal age at conception of index
child, and sex, birth weight, and gestational age of index child (Table 1). Average age of
conception of index child in case mothers was 29.01 with standard deviation of 6.56 and
overall range of 17.6 to 43.9 years. Average age of conception of index child in control
mothers was 27.36 with standard deviation of 6.71 and overall range of 16.9 to 38.9 years.
Males constituted 96% of case children and 72% of control children. Average birth weight of
case children was 109.75 ounces with standard deviation of 20.81 and overall range 70 to
152 ounces, whereas average birthweight in control children was 115.8 ounces with standard
deviation 13.93 and overall range of 92 to 136 ounces. Average gestational age was 37.44
weeks for case children, standard deviation 2.04 and overall range 32 to 40 weeks, and 39.3
weeks for control children, standard deviation 1.12 and overall range 37 to 42 weeks. Due to
limited funding, cases and controls were not matched.
There were no meaningful differences between the age at conception or birth weight
of cases and controls. A Wilcoxon rank sum was executed for age at conception, birth
weight, and gestational age because the data was nonparametric. Wilcoxon rank sum
indicated no difference in the median ages of conception between case and control mothers,
28.89 and 25.74 years, respectively (p = 0.432). There was no meaningful differences
between the medians of birthweight between cases and controls, 107 and 121 ounces,
respectively (p = 0.2002).
17

The proportion of male cases was larger than male controls (two-tailed p: 0.0206;
one-tailed p: 0.0103), which is consistent with research reflecting autism rates affecting
males 4 times higher than females (Baio, Wiggins, & Christensen, 2018). Wilcoxon rank sum
indicated a difference in gestational age medians of cases and controls, 38 and 40 weeks,
respectively (p = 0.0004).
Table 1: Descriptive statistics of known risk factors for mothers and index children
Variables
Mother
Age at Conception (years)
Index Child
Sex (percentage, male)
Birth Weight (ounces)
Gestational Age (weeks)

Cases (n=25), sd

Controls (n=25), sd

P-value

29.01, 6.56

27.36, 6.71

0.432

96, 109.75, 20.81
37.28, 2.04

72, 115.8, 13.93
39.3, 1.12

0.0206
0.2002
0.0004

Prevalence of Risk Factors
Two separate categories of prenatal risk factors were analyzed: maternal illness
during pregnancy and medications taken during pregnancy. The maternal illnesses surveyed
were urinary tract infections (UTIs), migraines, allergies, vaginal bleeding, and physical
injury. Mothers reported whether they experienced any of the illness at any point during
index pregnancy (Table 2) (Figure 2). All illnesses were reported more often in cases than
controls.
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Table 2: Differences in prevalence (counts) of reported maternal illnesses during gestation
of index pregnancy

Maternal Illnesses
Urinary tract infections (UTIs)
Migraines
Allergies
Vaginal bleeding
Physical injury

Count of Cases Count of Controls Fisher's
(n=25)
(n=25)
exact
10
2
0.018
6
3
0.463
10
3
0.051
9
2
0.037
6
4
0.496

Figure 3: Reported maternal illnesses during gestation of index pregnancy
12
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Mothers also reported whether they took any of the following medications or
medications for ailments at least once during their index pregnancy: Tylenol, antibiotics of
any kind, ibuprofen, allergy medication, pain medication, and cold medication (Table 3). All
medications were reported more often in cases than controls.
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Table 3: Differences in prevalence (counts) of reported maternal medications taken during
gestation of index pregnancy

Maternal Medications

Count of Cases
(n=25)

Tylenol
Antibiotics
Ibuprofen
Allergy medications
Pain medications
Cold medications

Count of Controls Fisher's
(n=25)
exact

14
7
7
7
11
7

10
2
2
2
6
2

0.396
0.138
0.138
0.138
0.232
0.138

Figure 4: Reported maternal medications taken during gestation of index pregnancy
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Measures of Association concerning Prevalence
Odds ratios were calculated conducted to measure the association between the
individual maternal illnesses and ASD (Table 4) and maternal medications and ASD (Table
5).
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Table 4: Odds ratios of reported maternal illnesses during gestation of index pregnancy
Maternal illnesses reported
during gestation
Urinary tract infections (UTIs)
Migraines
Allergies
Vaginal bleeding
Injury

95% Confidence
Odds ratio Interval
p-value
7.667
[1.470, 39.987]
0.008
2.316
[.509, 10.543]
0.270
4.889
[1.150, 20.790]
0.024
6.469
[1.230, 34.011]
0.017
1.750
[.426, 7.190]
0.435

Table 5: Odds ratios of reported maternal medications taken during gestation of index
pregnancy
Maternal medications reported
taken during gestation

Odds
ratio

95% Confidence
Interval

p-value

Tylenol

1.909

[.620, 5.876]

0.258

Antibiotics

4.472

[.827, 24.193]

0.066

Ibuprofen

4.472

[.827, 24.193]

0.066

Allergy medications

4.472

[.827, 24.193]

0.066

Pain medications

2.488

[.741, 8.350]

0.136

Cold medications

4.472

[.827, 24.193]

0.066
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DISCUSSION
The authors of this study acknowledge that the small sample size (n = 25) reduces the
power of the study, and thereby the ability to detect meaningful differences between the two
groups. However, a comprehensive view of statistical significance, point estimates, and
confidence intervals can provide meaningful implications of the results.
While all illnesses were reported more often in cases than controls, meaningful
differences in counts were calculated through Chi-squared analysis of vaginal bleeding and
UTIs (Table 2). This is corroborated by confidence intervals indicating a positive association
between vaginal bleedings, UTIs, and ASD in the child (Table 4). The confidence intervals
are extremely wide, indicating a lack of precision in the point estimate and low statistical
quality. However, the high upper limits of the confidence intervals and positive association
of the exposure to the outcome could provide clinical or practical implications that UTIs and
vaginal bleeding are potential prenatal risk factors to further investigate. These implications
can also be applied to the other illnesses that were not evaluated to be statistically significant
by p-values or confidence intervals. Point estimates of all maternal illnesses were positive,
indicating a general positive association between the prenatal risk factors and the outcome of
ASD.
Urinary tract infections (UTIs)
The odds of ASD in the index child are 7.667 times greater when born to mothers
who experienced UTIs during gestation of the child than those who did not (CI: [1.470,
37.987], p = 0.008) (Table 4). Previous case-control studies investigating the risk between
maternal infections during pregnancy and risk of ASD found a mild, but significant
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association between maternal bacterial infections in the second trimester and ASD. Overall,
women with bacterial infections diagnosed during hospital admissions were at increased risk
of delivering a child with ASD (ORadj: 1.58; 95% CI: 1.06-2.37). Genitourinary infections
were one of the most commonly diagnosed infections during pregnancy, with UTIs being
among the most common of the genitourinary type. Bacterial infections during pregnancy in
the second and third trimesters were also associated with a moderately increased ASD risk.
UTIs were the most common bacterial infections in the third trimester (Zerbo, et al., 2016).
Vaginal Bleeding
The odds of ASD in the index child are 6.469 times greater when born to mothers
who experienced vaginal bleeding during gestation of the child than those who did not (CI:
[1.230, 34.012], p = 0.017) (Table 4). Increased prevalence of vaginal bleeding in this study
is consistent with past peer-reviewed studies of prenatal factors, which found that 16.7% of
case mothers experienced vaginal bleeding. This was significantly higher than the national
rate of gestational vaginal bleeding of 6.6% (p = 0.001) (Brimacombe, Ming, & Lamendola,
2007). In this study, 36% of case mothers experienced vaginal bleeding and the most recent
rate for the state of Texas is 20.8% (PRAMS, 2011).
Allergies
The odds of ASD in the index child are 4.889 times greater when born to mothers
who experienced allergies during gestation of the child than those who did not (CI: [1.150,
20.790], p = 0.024). Ongoing research has attempted to link allergic conditions with
autoimmune disorders because they are both hypersensitivity responses (Sayed, Christy,
Quirion, & Brown, 2008). One study found elevated ASD risk for maternal allergy diagnoses
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during the second trimester of pregnancy (ORadj: 2.5, 95% CI: 1.2 – 5.2) (Croen, Grether, &
Yoshida, 2005).
Maternal medications
Statistically, no maternal medications demonstrated significant difference in
prevalence counts or point estimates. However, all point estimates were positive and the
upper limit of the confidence intervals were high (ranging from 8.35 to 24.193, Table 5).
Prior studies strongly suggest a relationship between medication mechanism and autism
development, specifically Tylenol. While acetaminophen (Tylenol) is typically used to
reduce inflammation, studies show that even low doses of the drug can induce immune
system activation and oxidative stress responses associated with autism development (Parker,
et al., 2017).
An additional evaluation elicited from this study is that maternal illnesses and
maternal medications were more frequently reported across all variables in case mothers.
While this may be a result of recall bias, it may also indicate behavioral patterns of frequent
illness or medication consumption in mothers who will give birth to children with autism.
Limitations
One major limitation of this pilot study is its small sample size. Because this is a pilot
study, the researchers only had enough funding for 25 cases and 25 controls. Subsequently,
the small sample size may not provide enough statistical power to detect significant results in
variables measured. In future research, the power could be improved by adjusting the type I
error level to reflect the sample size and variability of the data. Another way to improve
power is increasing the sample size with increased funding and greater recruiting.
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Another consequence of limited funding and small sample size is that confounders
could not be addressed. The author is aware there are many variables that may ask as
confounders to autism risk, including but not limited to: infant sex, infant birth weight, and
maternal age at conception (Goines, et al., 2011). Frequency matching for these variables
was not economically feasible, and the sample size was too small for logistic regression.
This study only measured occurrence of prenatal risk factors and did not delve deeper
into timing of the infection. As critical as timing is in fetal development, it would be prudent
to accurately identify the timing of the symptoms as way of identifying which point in the
gestational pathway maternal inflammation is most potent.
Lastly, all data was self-reported by the mothers retroactively and is subject to recall
bias. Survey responses were not cross-referenced with medical records due to lack of
funding, so all data is reliant on maternal recall.
Strengths
The results of our analysis of data collected in this preliminary pilot study are
consistent with the idea that maternal inflammation increases risk for autism in the child.
Additionally, we found meaningful differences in prevalence and odds of vaginal bleeding,
UTIs, and allergies during gestation. These trends have also been studied and supported in
numerous past peer-reviewed studies of larger scale (Brimacombe, Ming, & Lamendola,
2007) (Zerbo, et al., 2016) (Croen, Grether, & Yoshida, 2005).
Additionally, this study used a very specific sample of Hispanic women and children
who live on the Texas/Mexico border. While this group has typically lower diagnosis rates of
ASD, the data of this small study on a specific group of individuals is consistent with larger
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studies concerning all races and ethnicities. The finding that prenatal risk factors can
similarly influence Hispanic women and their children as they do other women and children
strengthens the idea that the Hispanic children are underdiagnosed and there is not a
protective genetic component in Hispanics.
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CONCLUSION
The current pilot study and past peer-reviewed literature indicate a strong association
between prenatal risk factors and autism risk in the child. This association is supported by
research of maternal inflammation and its role in fetal neurodevelopment. As a result, three
prenatal risk factors were found to have association with ASD should be studied further for
their role in autism risk: maternal vaginal bleeding, UTIs, and allergies. Early identification
and treatment of these risk factors during gestation may play a role in reducing ASD risk.
This research has the potential to significantly impact the health and quality of life of
Hispanic women and children living on the Texas/Mexico border. This population is
medically underserved, and as a result autism is underdiagnosed. Identification and
appropriate treatment of the prenatal risk factors should be taught to local clinicians and
community health workers. The public health community can use this data to create
awareness and educate Hispanic women on risk factors to be mindful of while they are
pregnant.
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